These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26116386)

  • 1. Preparation, characterization and molecular modeling of PEGylated human growth hormone with agonist activity.
    Khameneh B; Jaafari MR; Hassanzadeh-Khayyat M; Varasteh A; Chamani J; Iranshahi M; Mohammadpanah H; Abnous K; Saberi MR
    Int J Biol Macromol; 2015 Sep; 80():400-9. PubMed ID: 26116386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical and enzymatic site specific PEGylation of hGH.
    da Silva Freitas D; Mero A; Pasut G
    Bioconjug Chem; 2013 Mar; 24(3):456-63. PubMed ID: 23432141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical and Enzymatic Site Specific PEGylation of hGH: The Stability and in vivo Activity of PEG-N-Terminal-hGH and PEG-Gln141-hGH Conjugates.
    Grigoletto A; Mero A; Zanusso I; Schiavon O; Pasut G
    Macromol Biosci; 2016 Jan; 16(1):50-6. PubMed ID: 26350165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new method to increase selectivity of transglutaminase mediated PEGylation of salmon calcitonin and human growth hormone.
    Mero A; Schiavon M; Veronese FM; Pasut G
    J Control Release; 2011 Aug; 154(1):27-34. PubMed ID: 21565230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new site-specific monoPEGylated filgrastim derivative prepared by enzymatic conjugation: Production and physicochemical characterization.
    Scaramuzza S; Tonon G; Olianas A; Messana I; Schrepfer R; Orsini G; Caliceti P
    J Control Release; 2012 Dec; 164(3):355-63. PubMed ID: 22735238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoform separation and structural identification of mono-PEGylated recombinant human growth hormone (PEG-rhGH) with pH gradient chromatography.
    Qin X; Li J; Li Y; Gan Y; Huang H; Liang C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():206-213. PubMed ID: 28153672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel high-throughput screening method for microbial transglutaminases with high specificity toward Gln141 of human growth hormone.
    Zhao X; Shaw AC; Wang J; Chang CC; Deng J; Su J
    J Biomol Screen; 2010 Feb; 15(2):206-12. PubMed ID: 20086216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenyl amide linker improves the pharmacokinetics and pharmacodynamics of N-terminally mono-PEGylated human growth hormone.
    Wu L; Ji S; Shen L; Hu T
    Mol Pharm; 2014 Sep; 11(9):3080-9. PubMed ID: 25115329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site specific PEGylation of β-lactoglobulin at glutamine residues and its influence on conformation and antigenicity.
    Luo S; Lu X; Liu C; Zhong J; Zhou L; Chen T
    Food Res Int; 2019 Sep; 123():623-630. PubMed ID: 31285011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precise and combinatorial PEGylation generates a low-immunogenic and stable form of human growth hormone.
    Wu L; Chen J; Wu Y; Zhang B; Cai X; Zhang Z; Wang Y; Si L; Xu H; Zheng Y; Zhang C; Liang C; Li J; Zhang L; Zhang Q; Zhou D
    J Control Release; 2017 Mar; 249():84-93. PubMed ID: 28131652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transglutaminase-mediated PEGylation of proteins: direct identification of the sites of protein modification by mass spectrometry using a novel monodisperse PEG.
    Mero A; Spolaore B; Veronese FM; Fontana A
    Bioconjug Chem; 2009 Feb; 20(2):384-9. PubMed ID: 19186937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pegylated peptides. IV. Enhanced biological activity of site-directed pegylated GRF analogs.
    Felix AM; Lu YA; Campbell RM
    Int J Pept Protein Res; 1995; 46(3-4):253-64. PubMed ID: 8537179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.
    Basu A; Yang K; Wang M; Liu S; Chintala R; Palm T; Zhao H; Peng P; Wu D; Zhang Z; Hua J; Hsieh MC; Zhou J; Petti G; Li X; Janjua A; Mendez M; Liu J; Longley C; Zhang Z; Mehlig M; Borowski V; Viswanathan M; Filpula D
    Bioconjug Chem; 2006; 17(3):618-30. PubMed ID: 16704199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Troubleshooting PEG-hGH detection supporting pharmacokinetic evaluation in growth hormone deficient patients.
    Myler HA; McVay S; Kratzsch J
    J Pharmacol Toxicol Methods; 2010; 61(2):92-7. PubMed ID: 20044010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specific PEGylation for high-yield preparation of Lys(21)-amine PEGylated growth hormone-releasing factor (GRF) (1-29) using a GRF(1-29) derivative FMOC-protected at Tyr(1) and Lys(12).
    Youn YS; Lee KC
    Bioconjug Chem; 2007; 18(2):500-6. PubMed ID: 17243755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase.
    Fontana A; Spolaore B; Mero A; Veronese FM
    Adv Drug Deliv Rev; 2008 Jan; 60(1):13-28. PubMed ID: 17916398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiolated glycol chitosan bearing α-cyclodextrin for sustained delivery of PEGylated human growth hormone.
    Sivasubramanian M; Kim YJ; Chae SY; Son S; Jo DG; Lee KC; Yoo CK; Park JH
    J Biomater Sci Polym Ed; 2012; 23(15):1995-2005. PubMed ID: 22040402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transglutaminase-mediated methods for site-selective modification of human growth hormone.
    Buchardt J; Selvig H; Nielsen PF; Johansen NL
    Biopolymers; 2010; 94(2):229-35. PubMed ID: 20225295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMR structure of two novel polyethylene glycol conjugates of the human growth hormone-releasing factor, hGRF(1-29)-NH2.
    Digilio G; Barbero L; Bracco C; Corpillo D; Esposito P; Piquet G; Traversa S; Aime S
    J Am Chem Soc; 2003 Mar; 125(12):3458-70. PubMed ID: 12643708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Terminal Modification with Pseudo-Bifunctional PEG-Hexadecane Markedly Improves the Pharmacological Profile of Human Growth Hormone.
    Wu L; Ji S; Hu T
    Mol Pharm; 2015 May; 12(5):1402-11. PubMed ID: 25849255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.